Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.

Roberts LM, Davies JS, Sempowski GD, Frelinger JA.

Vaccine. 2014 Jun 17;32(29):3595-603. doi: 10.1016/j.vaccine.2014.05.013. Epub 2014 May 14.

2.

Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.

Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.

J Immunol. 2010 May 15;184(10):5791-801. doi: 10.4049/jimmunol.1000362. Epub 2010 Apr 14.

3.

Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.

Infect Immun. 2013 Sep;81(9):3099-105. doi: 10.1128/IAI.00203-13. Epub 2013 Jun 17.

5.

Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.

Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA.

Infect Immun. 2013 Jun;81(6):2028-42. doi: 10.1128/IAI.00207-13. Epub 2013 Mar 25.

6.

Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).

De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.

MBio. 2014 Apr 8;5(2):e00936. doi: 10.1128/mBio.00936-13.

7.

Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP.

Clin Vaccine Immunol. 2009 Apr;16(4):444-52. doi: 10.1128/CVI.00405-08. Epub 2009 Feb 11.

8.

Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection.

Furuya Y, Kirimanjeswara GS, Roberts S, Metzger DW.

Infect Immun. 2013 Sep;81(9):3434-41. doi: 10.1128/IAI.00408-13. Epub 2013 Jul 8.

9.

T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.

Melillo AA, Foreman O, Bosio CM, Elkins KL.

Infect Immun. 2014 Apr;82(4):1477-90. doi: 10.1128/IAI.01545-13. Epub 2014 Jan 13.

11.

Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

Anderson RV, Crane DD, Bosio CM.

Vaccine. 2010 Sep 14;28(40):6562-72. doi: 10.1016/j.vaccine.2010.07.072. Epub 2010 Aug 3.

12.

Identification of a live attenuated vaccine candidate for tularemia prophylaxis.

Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS.

PLoS One. 2013 Apr 17;8(4):e61539. doi: 10.1371/journal.pone.0061539. Print 2013.

13.

Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.

Woolard MD, Hensley LL, Kawula TH, Frelinger JA.

Infect Immun. 2008 Jun;76(6):2651-9. doi: 10.1128/IAI.01412-07. Epub 2008 Apr 7.

14.

CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.

Powell HJ, Cong Y, Yu JJ, Guentzel MN, Berton MT, Klose KE, Murthy AK, Arulanandam BP.

Immunol Cell Biol. 2008 Aug-Sep;86(6):515-22. doi: 10.1038/icb.2008.31. Epub 2008 Apr 22.

PMID:
18427567
15.

T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.

Collazo CM, Meierovics AI, De Pascalis R, Wu TH, Lyons CR, Elkins KL.

Infect Immun. 2009 May;77(5):2010-21. doi: 10.1128/IAI.01322-08. Epub 2009 Feb 23.

16.

Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strain.

De Pascalis R, Taylor BC, Elkins KL.

Infect Immun. 2008 Sep;76(9):4311-21. doi: 10.1128/IAI.00514-08. Epub 2008 Jun 23.

18.

Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.

Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.

Vaccine. 2009 Sep 18;27(41):5554-61. doi: 10.1016/j.vaccine.2009.07.034. Epub 2009 Aug 3.

19.

An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.

Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.

Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8.

Items per page

Supplemental Content

Write to the Help Desk